These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16192913)

  • 1. Occupational bladder cancer: from cohort study to biologic molecular marker.
    Matsumoto K; Irie A; Satoh T; Kuruma H; Arakawa T; Baba S
    Med Sci Monit; 2005 Oct; 11(10):RA311-5. PubMed ID: 16192913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematuria screening for bladder cancer.
    Messing EM; Vaillancourt A
    J Occup Med; 1990 Sep; 32(9):838-45. PubMed ID: 2074507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
    Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
    Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer screening at the Dupont Chambers Works: a new initiative.
    Mason TJ; Vogler WJ
    J Occup Med; 1990 Sep; 32(9):874-7. PubMed ID: 2074511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
    Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
    Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.
    Clin B; ; Pairon JC
    BMC Public Health; 2014 Nov; 14():1155. PubMed ID: 25377503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational bladder cancer in textile dyeing and printing workers: six cases and their significance for screening programs.
    Frumin E; Velez H; Bingham E; Gillen M; Brathwaite M; LaBarck R
    J Occup Med; 1990 Sep; 32(9):887-90. PubMed ID: 2074514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer screening in aluminum smelter workers.
    Taiwo OA; Slade MD; Cantley LF; Tessier-Sherman B; Galusha D; Kirsche SR; Donoghue AM; Cullen MR
    J Occup Environ Med; 2015 Apr; 57(4):421-7. PubMed ID: 25525927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
    Roobol MJ; Bangma CH; el Bouazzaoui S; Franken-Raab CG; Zwarthoff EC
    Urol Oncol; 2010; 28(6):686-90. PubMed ID: 21062653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
    Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
    J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and etiology of human bladder cancer: occupational bladder cancer in the British rubber industry.
    Parkes HG
    J Natl Cancer Inst; 1969 Jul; 43(1):249-52. PubMed ID: 5796387
    [No Abstract]   [Full Text] [Related]  

  • 14. Occupational exposure to carbon black and risk of bladder cancer.
    Puntoni R; Ceppi M; Reggiardo G; Merlo F
    Lancet; 2001 Aug; 358(9281):562. PubMed ID: 11520532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of a screening method for occupational bladder cancer].
    Borchini R; Bonzini M; Veronesi G; Fava C; Carenzi MC; Mombelli S; Marconi A; Bono AV; Ferrario MM
    Med Lav; 2009; 100(6):438-47. PubMed ID: 20359136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening workers exposed to 4,4'-methylenebis(2-chloroaniline) for bladder cancer by cystoscopy.
    Ward E; Halperin W; Thun M; Grossman HB; Fink B; Koss L; Osorio AM; Schulte P
    J Occup Med; 1990 Sep; 32(9):865-8. PubMed ID: 2074509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective external validation of a bladder cancer detection model.
    Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
    J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative fluorescence image analysis in bladder cancer screening.
    Hemstreet GP; Hurst RE; Bass RA; Rao JY
    J Occup Med; 1990 Sep; 32(9):822-8. PubMed ID: 2074505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in screening protocols for the detection of early bladder cancer.
    Geller AC; Brooks DR; Barber CE; Koh HK; Lew RA; Wax S; Prout MN
    J Occup Med; 1990 Sep; 32(9):929-35. PubMed ID: 2074522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk patients with hematuria are not evaluated according to guideline recommendations.
    Elias K; Svatek RS; Gupta S; Ho R; Lotan Y
    Cancer; 2010 Jun; 116(12):2954-9. PubMed ID: 20564400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.